The company, founded in 2018 and headquartered in Cambridge, Massachusetts, applies a systematic approach for single-cell sequencing to discover precision therapies. By combining massive datasets and algorithms, Celsius Therapeutics identifies genes that causally contribute to disease. The community of scientists, technologists, clinicians, and drug hunters fosters innovation, teamwork, and excellence in a rigorous, fast-paced, and collaborative environment. Celsius Therapeutics is committed to attracting and retaining the best talent to drive growth and success towards their mission of improving human health.